On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.